Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Screening for Type 2 Diabetes in Unconventional Settings Simplified

By LabMedica International staff writers
Posted on 15 Sep 2011
A simple blood test at high street opticians could help to diagnose diabetes. More...
People who do not routinely visit their GP could also be screened in their chiropodist's or dentist's office, or even in pharmacies.

A pilot study, carried out by the Center for Integrated Healthcare Research, School of Medicine and Health, Wolfson Research Institute, Durham University (Stockton-on-Tees, United Kingdom) and The William Kelly Diabetes Center, The James Cook University Hospital, (Middlesbrough, United Kingdom) focused on opticians.
Out of 1,000 people visiting their opticians for an eye test who were found to have one or more risk factors of diabetes, such as increased body mass index or aged over 40, almost 32% were referred to their GP for further investigation after having their blood glucose levels checked.

Currently, most screening for diabetes is carried out in medical settings, mostly by family doctors, but there are many people who do not visit their GP for preventative care, even if they are in an at-risk group. The pilot study indicates that opticians are an under-utilized resource in the efforts to identify the large numbers of people with undiagnosed diabetes.

The findings of this study were published in the July 1, 2011, British Journal of General Practice. Lead author Dr Jenny Howse from Durham University's School of Medicine and Health, said, "The screening test is less invasive and time consuming than fasting blood glucose and oral glucose tolerance tests. Already pharmacists and chiropodists have shown it is feasible to offer screening in their practices, here in the UK as well as in Australia and Switzerland. In the US, 60% of adults visit dentists at least once a year for standard check-ups and those practices could be suitable locations to screen for diabetes."

"In the UK, our initial results show screening for diabetes in opticians is a feasible option but we now need to look at the practicalities of delivering it, including liaison between opticians and GPs and the time costs for opticians."

Related Links:

Durham University




Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
Urine Analyzer
respons® UDS100
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: The study compares rapid molecular CPE diagnostics, which can return results in about one hour, with culture-based screening, which typically takes about 48 hours (Image credit: Adobe Stock)

Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE

Drug-resistant infections remain a critical patient-safety threat in hospitals, with carbapenemase-producing Enterobacterales (CPE) among the most urgent concerns. In England, reports of acquired carbapenemase... Read more

Pathology

view channel
Image: The VENTANA PTEN (SP218) RxDx Assay is a qualitative IHC assay for assessing PTEN protein in prostate adenocarcinoma, with staining performed using the OptiView DAB IHC Detection Kit on a BenchMark ULTRA instrument (Photo courtesy of Roche)

New Companion Diagnostic Expands Precision Medicine in Prostate Cancer

Prostate cancer is a leading cancer diagnosis in men and becomes particularly aggressive when it presents as metastatic, hormone-sensitive disease. Tumors with loss of phosphatase and tensin homolog (PTEN)... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.